21 – 30 of 37
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2010
-
Mark
The clinical use of N-terminal-pro brain natriuretic peptide in elderly patients with mental illness.
(
- Contribution to journal › Article
-
Mark
Plasma Homocysteine and Cognition in Elderly Patients with Dementia or Other Psychogeriatric Diseases.
(
- Contribution to journal › Article
-
Mark
Plasma homocysteine, apolipoprotein E status and vascular disease in elderly patients with mental illness.
(
- Contribution to journal › Article
-
Mark
Plasma homocysteine-a marker of vascular disease in elderly patients with mental illness.
(
- Contribution to journal › Article
- 2009
-
Mark
Association between plasma homocysteine levels and mortality in elderly patients with mental illness.
(
- Contribution to journal › Article
-
Mark
Plasma Homocysteine Levels and Different Forms of Vascular Disease in Patients with Dementia and Other Psychogeriatric Diseases.
(
- Contribution to journal › Article
-
Mark
A Swedish family with de novo alpha-synuclein A53T mutation: Evidence for early cortical dysfunction.
(
- Contribution to journal › Article
-
Mark
Reduced CSF CART in dementia with Lewy bodies.
(
- Contribution to journal › Article
- 2008
-
Mark
Homocysteine, cystatin C and N-terminal-pro brain natriuretic Peptide. Vascular risk markers in elderly patients with mental illness.
(
- Contribution to journal › Article
-
Mark
Plasma homocysteine and vascular disease in elderly patients with mental illness
(
- Contribution to journal › Scientific review